ABSTRACT
BACKGROUND: Medical record review is the gold standard method of identifying adverse events. However, the quality of medical records is a critical factor that can affect the accuracy of adverse event detection. Few studies have examined the impact of medical record quality on the identification of adverse events. OBJECTIVES: In this study, we analyze whether there were differences in screening criteria and characteristics of adverse events according to the quality of medical records evaluated in the patient safety incident inquiry in Korea. METHODS: Patient safety incident inquiry was conducted in 2019 on 7500 patients in Korea to evaluate their screening criteria, adverse events, and preventability. Furthermore, medical records quality judged by reviewers was evaluated on a 4-point scale. The χ 2 test was used to examine differences in patient safety incident inquiry results according to medical record quality. RESULTS: Cases with inadequate medical records had higher rates of identified screening criteria than those with adequate records (88.8% versus 55.7%). Medical records judged inadequate had a higher rate of confirmed adverse events than those judged adequate. "Drugs, fluids, and blood-related events," "diagnosis-related events," and "patient care-related events" were more frequently identified in cases with inadequate medical records. There was no statistically significant difference in the preventability of adverse events according to the medical record quality. CONCLUSIONS: Lower medical record quality was associated with higher rates of identified screening criteria and confirmed adverse events. Patient safety incident inquiry should specify medical record quality evaluation questions more accurately to more clearly estimate the impact of medical record quality.
Subject(s)
Medical Errors , Medical Records , Patient Safety , Humans , Patient Safety/standards , Patient Safety/statistics & numerical data , Republic of Korea , Medical Errors/statistics & numerical data , Medical Errors/prevention & control , Medical Records/standards , Risk Management/methods , Risk Management/statistics & numerical dataABSTRACT
Objetivo: identificar o perfil medicamentoso e a frequência de polifarmácia em idosos cadastrados e que fazem acompanhamento em uma unidade básica de saúde. Método: estudo observacional e retrospectivo, realizado em uma unidade básica de saúde de um município do Triângulo Mineiro, Minas Gerais. Foi realizada amostragem aleatória e estratificada para coleta de dados de prontuários físicos e eletrônicos de idosos atendidos nos anos de 2019 e 2020, analisados por meio de estatística descritiva. Resultados: entre 448 prontuários foram analisados, porém somente 208 (46,4%) foram válidos. Os medicamentos mais prescritos foram losartana (n=72; 34,6%), sinvastatina (n=60; 28,8%) e metformina (n=51; 24,5%). Observou-se 24,0% de frequência de polifarmácia (n=51), maior frequência de mulheres (n=42; 30,2%) e com significativa associação com diabetes mellitus (p=0,034). Conclusão: a polifarmárcia foi detectada, mais presente nas mulheres, sendo que medicamentos mais utilizados foram relacionados à hipertensão arterial, dislipidemias e diabetes mellitus. Destaca-se a incompletude de informações nos prontuários analisados(AU)
Objective: to identify the medication profile and frequency of polypharmacy in registered elderly people who are followed up at a primary care unit. Method: observational and retrospective study, carried out in a primary care unit in a municipality in Triângulo Mineiro, Minas Gerais. Random and stratified sampling was carried out to collect data from the physical and electronic medical records of the elderly assisted in the years 2019 and 2020, analyzed using descriptive statistics. Results: among 448 medical records analyzed, 208 (46.4%) were considered valid for inclusion in the study. The most prescribed drugs were losartan (n=72; 34.6%), simvastatin (n=60; 28.8%) and metformin (n=51; 24.5%). There was a 24.0% frequency of polypharmacy (n=51), a higher frequency of wome (n=42; 30.2%) and with a significant association with diabetes mellitus (p=0.034). Conclusion: polypharmacy was detected, more present in women, and the most used drugs were related to arterial hypertension, dyslipidemia and diabetes mellitus. The incompleteness of information in the analyzed medical records stands out. Descriptors: Health of the Elderly; Aged; Primary Health Care; Polypharmacy(AU)
Objetivo: identificar el perfil farmacológico y frecuencia de polifarmacia en ancianos registrados en seguimiento en una unidad básica de salud. Método: estudio observacional y retrospectivo, realizado en una unidad básica de salud de un municipio del Triângulo Mineiro, Minas Gerais. Se realizó un muestreo aleatorio y estratificado para recolectar datos de las historias clínicas físicas y electrónicas de los ancianos atendidos en los años 2019 y 2020, analizados mediante estadística descriptiva. Resultados: de 448 historias clínicas analizadas, 208 (46,4%) fueron consideradas válidas para su inclusión en el estudio. Los fármacos más prescritos fueron Losartán (n=72; 34,6%), Simvastatina (n=60; 28,8%) y Metformina (n=51; 24,5%). La frecuencia de polifarmacia estuvo en el 24,0% (n=51), mayor frecuencia de mujeres (n=42; 30,2%) y con asociación significativa con diabetes mellitus (p=0,034). Conclusión: se detectó la polifarmacia, más presente en las mujeres; los fármacos más utilizados estuvieron relacionados con hipertensión arterial, dislipidemia y diabetes mellitus. Se destaca la incompletitud de la información en las historias clínicas analizadas(AU)
Subject(s)
Humans , Male , Female , Middle Aged , Aged , Aged, 80 and over , Health of the Elderly , Polypharmacy , Drug Therapy/nursing , Health Centers , Medical Records/standards , Retrospective StudiesABSTRACT
Importance: There is increased interest in and potential benefits from using large language models (LLMs) in medicine. However, by simply wondering how the LLMs and the applications powered by them will reshape medicine instead of getting actively involved, the agency in shaping how these tools can be used in medicine is lost. Observations: Applications powered by LLMs are increasingly used to perform medical tasks without the underlying language model being trained on medical records and without verifying their purported benefit in performing those tasks. Conclusions and Relevance: The creation and use of LLMs in medicine need to be actively shaped by provisioning relevant training data, specifying the desired benefits, and evaluating the benefits via testing in real-world deployments.
Subject(s)
Language , Machine Learning , Medical Records , Medicine , Medical Records/standards , Medicine/methods , Medicine/standards , Computer SimulationSubject(s)
Breast Density , Breast Diseases , Health Communication , Mammography , Medical Records , Breast/diagnostic imaging , Breast Diseases/diagnostic imaging , Breast Diseases/pathology , Disclosure/standards , Health Communication/methods , Health Communication/standards , Mammography/methods , Mammography/standards , Medical Records/standards , United States Food and Drug Administration/standards , United StatesSubject(s)
Biomedical Research , Informed Consent , Medical Records , Patient Rights , Specimen Handling , Biomedical Research/ethics , Biomedical Research/standards , Confidentiality/standards , Disclosure/standards , Informed Consent/standards , Medical Records/standards , Patient Rights/standards , Specimen Handling/ethics , Specimen Handling/standards , Surveys and QuestionnairesABSTRACT
This study aimed to document the experience of integration and the contribution of the Client Tracker (CT) to female genital fistula (FGF) management and data quality in sites supported by the Fistula Care+ Project in the Democratic Republic of Congo (DRC), from 2017 to 2019. It was a parallel mixed methods study using routine quantitative data and qualitative data from in-depth interviews with the project staff. Quantitative findings indicated that CT forms were present in the medical records of 63% of patients; of these, 38% were completely filled out, and 29% were correctly filled out. Qualitative findings suggested that the level of use of CT in the management of FGF was associated with staff familiarity with the CT, staff understanding of concepts in the CT forms, and the CT-related additional workload. The CT has mainly contributed to improving data quality and reporting, quality of care, follow-up of fistula patients, and self-supervision of management activities. A possible simplification of the CT and/or harmonization of its content with existing routine forms, coupled with adequate continuous training of staff on record-keeping, would further contribute to maximizing CT effectiveness and sustainability.
Subject(s)
Fistula , Genital Diseases, Female , Medical Records , Democratic Republic of the Congo , Female , Fistula/diagnosis , Fistula/therapy , Genital Diseases, Female/diagnosis , Genital Diseases, Female/therapy , Humans , Medical Records/standardsABSTRACT
When multiple cores are biopsied from a single magnetic resonance imaging (MRI)-targeted lesion, Gleason grade may be assigned for each core separately or for all cores of the lesion in aggregate. Because of the potential for disparate grades, an optimal method for pathology reporting MRI lesion grade awaits validation. We examined our institutional experience on the concordance of biopsy grade with subsequent radical prostatectomy (RP) grade of targeted lesions when grade is determined on individual versus aggregate core basis. For 317 patients (with 367 lesions) who underwent MRI-targeted biopsy followed by RP, targeted lesion grade was assigned as (1) global Grade Group (GG), aggregated positive cores; (2) highest GG (highest grade in single biopsy core); and (3) largest volume GG (grade in the core with longest cancer linear length). The 3 biopsy grades were compared (equivalence, upgrade, or downgrade) with the final grade of the lesion in the RP, using κ and weighted κ coefficients. The biopsy global, highest, and largest GGs were the same as the final RP GG in 73%, 68%, 62% cases, respectively (weighted κ: 0.77, 0.79, and 0.71). For cases where the targeted lesion biopsy grade scores differed from each other when assigned by global, highest, and largest GG, the concordance with the targeted lesion RP GG was 69%, 52%, 31% for biopsy global, highest, and largest GGs tumors (weighted κ: 0.65, 0.68, 0.59). Overall, global, highest, and largest GG of the targeted biopsy show substantial agreement with RP-targeted lesion GG, however targeted global GG yields slightly better agreement than either targeted highest or largest GG. This becomes more apparent in nearly one third of cases when each of the 3 targeted lesion level biopsy scores differ. These results support the use of global (aggregate) GG for reporting of MRI lesion-targeted biopsies, while further validations are awaited.
Subject(s)
Image-Guided Biopsy/standards , Magnetic Resonance Imaging, Interventional/standards , Neoplasm Grading/standards , Prostatic Neoplasms/pathology , Adult , Aged , Aged, 80 and over , Biopsy, Large-Core Needle/standards , Humans , Male , Medical Records/standards , Middle Aged , Predictive Value of Tests , Prostatectomy , Prostatic Neoplasms/surgery , Reproducibility of Results , Retrospective StudiesABSTRACT
The clinical history is the cornerstone of the doctor's work. When assessing patients consulting for a suspected hypersensitivity reactionto a drug, the details collected in the patient's clinical history are essential when deciding which tests to perform and for makingrecommendations about which drugs the patient should avoid and which can be taken. This area is especially important today, since manypatients are labeled as allergic to drugs, especially penicillins, without this being the case. This article reviews the importance of the clinicalhistory in a patient with a hypersensitivity reaction to a drug and considers which data should be collected. Likewise, a record-based modelis proposed to help standardize the clinical history (AU)
La historia clínica es la piedra angular del trabajo del médico. En el estudio de los pacientes que consultan por una supuesta reacción dehipersensibilidad a un fármaco, los detalles recogidos en la historia clínica del paciente son fundamentales para decidir el estudio quehay que realizar y para, al final, dar recomendaciones al paciente sobre los fármacos que debe evitar o que puede tomar. Actualmentecobra especial importancia este tema, dado que hay un elevado porcentaje de la población que, sin serlo, está etiquetada de alergiaa fármacos, sobre todo a las penicilinas. En este artículo se revisa la importancia que tiene la historia clínica ante un paciente con unareacción de hipersensibilidad a un fármaco y qué datos deben ser recogidos. Asimismo, se propone un modelo de ficha que puede ayudara la estandarización de la historia clínica (AU)
Subject(s)
Humans , Drug Hypersensitivity , Medical Records/standardsSubject(s)
Humans , Primary Health Care , Physicians, Family , Public Health , Medical Records/standardsABSTRACT
O objetivo deste estudo transversal foi avaliaro desfecho dor e fatores associados em pacientes atendidos em um serviço de urgência odontológica no sul do Brasil. Foram avaliados 137 prontuários provenientes de um projeto de extensão para capacitação em atendimento odontológico de urgência da Universidade Federal de Santa Maria (Santa Maria/RS), referentes ao período de abril de 2017 a dezembro de 2018. Os dados contidos na ficha clínica, autorrelatados pelos pacientes, foram coletados e variáveis relacionadas às características socioeconômicas, médicas e odontológicas foram submetidas à análise estatística descritiva e regressão de Poisson multivariada. A prevalência de dor nestes pacientes foi de 65,2%e a hipótese diagnósticamais prevalente foi de pulpite aguda irreversível (46,2% dos casos). A procura por atendimento foi maiorna faixa etária entre 40-59 anos (48,6%), no sexo feminino (64%), em pacientes sem nível superior (85,3%) e os dentes mais frequentemente tratados foram os posteriores (82,7%). Houve associação entre a presença de dor e variáveis médicas, sendo queos pacientes com mais de duas doençassistêmicas apresentaram maior prevalência de dor. O preenchimento inadequado dos prontuários odontológicos foi um achado comum, o que pode prejudicar o estabelecimento do perfil epidemiológico destes pacientes e o planejamento dos atendimentos futuros de forma eficiente, além de poder acarretar problemas jurídicos (AU).
This cross-sectional study aimed to evaluate the pain outcome and associated factorsin patients attending an emergency dental service in southern Brazil. One hundred and thirty-seven (137) patient records from an extension project for emergency dental care training at the Universidade Federal de Santa Maria (Santa Maria, RS, Brazil), relative to the period from April 2017 to December 2018, were evaluated. The data in the records, self-reported by the patients, were collected, and variables related to socioeconomic, medical and dental characteristics were subjected to descriptive statistical analysis and multivariate Poisson regression. The prevalence of pain in these patients was 65.2%, and the most prevalent diagnostic hypothesis was irreversible acute pulpitis (46.2% of the cases). The demand for care was greater in the age group between40-59 years (48.6%), in women (64%), in patients without university education (85.3%), and posterior teeth were the most frequently treated (82.7%). There was an association between the presence of pain and medical variables, being that patients with morethan two systemic diseases had a higher prevalence of pain. The inadequate completion of dental records was a common finding, which can impair the establishment of the epidemiological profile of these patients and the efficient planning of future dental care services, as well as cause legal problems (AU).
Subject(s)
Humans , Male , Female , Infant , Child, Preschool , Child , Adolescent , Adult , Middle Aged , Aged , Aged, 80 and over , Toothache/epidemiology , Health Profile , Dental Care , Emergency Treatment/instrumentation , Health Services Research/methods , Pain/epidemiology , Brazil/epidemiology , Medical Records/standards , Cross-Sectional Studies/methods , Multivariate Analysis , Regression AnalysisABSTRACT
BACKGROUND: Preterm birth is a leading cause of death among children under five years. Previous estimates indicated global preterm birth rate of 10.6% (14.8 million neonates) in 2014. We aim to update preterm birth estimates at global, regional, and national levels for the period 2010 to 2019. METHODS: Preterm birth is defined as a live birth occurring before 37 completed gestational weeks, or <259 days since a woman's last menstrual period. National administrative data sources for WHO Member States with facility birth rates of ≥80% in the most recent year for which data is available will be searched. Administrative data identified for these countries will be considered if ≥80% of UN estimated live births include gestational age information to define preterm birth. For countries without eligible administrative data, a systematic review of studies will be conducted. Research studies will be eligible if the reported outcome is derived from an observational or intervention study conducted at national or sub-national level in population- or facility-based settings. Risk of bias assessments will focus on gestational age measurement method and coverage, and inclusion of special subgroups in published estimates. Covariates for inclusion will be selected a priori based on a conceptual framework of plausible associations with preterm birth, data availability, and quality of covariate data across many countries and years. Global, regional and national preterm birth rates will be estimated using a Bayesian multilevel-mixed regression model. DISCUSSION: Accurate measurement of preterm birth is challenging in many countries given incomplete or unavailable data from national administrative sources, compounded by limited gestational age assessment during pregnancy to define preterm birth. Up-to-date modelled estimates will be an important resource to measure the global burden of preterm birth and to inform policies and programs especially in settings with a high burden of neonatal mortality. TRIAL REGISTRATION: PROSPERO registration: CRD42021237861.
Subject(s)
Medical Records/standards , Premature Birth/epidemiology , Bayes Theorem , Bias , Databases, Factual , Epidemiologic Studies , Female , Gestational Age , Global Health , Humans , Infant, Newborn , Infant, Premature , Pregnancy , Systematic Reviews as Topic , United Nations , World Health OrganizationABSTRACT
OBJECTIVE: The aim of this study was to evaluate the benefits and potential of structured reports (SR) for chest computed tomography after lung transplantation. METHODS: Free-text reports (FTR) and SR were generated for 49 computed tomography scans. Clinical routine reports were used as FTR. Two pulmonologists rated formal aspects, completeness, clinical utility, and overall quality. Wilcoxon and McNemar tests were used for statistical analysis. RESULTS: Structured reports received significantly higher ratings for all formals aspects (P < 0.001, respectively). Completeness was higher in SR with regard to evaluation of bronchiectases, bronchial anastomoses, bronchiolitic and fibrotic changes (P < 0.001, respectively), and air trapping (P = 0.012), but not signs of pneumonia (P = 0.5). Clinical utility and overall quality were rated significantly higher for SR than FTR (P < 0.001, respectively). However, report type did not influence initiation of further diagnostic or therapeutic measures (P = 0.307 and 1.0). CONCLUSIONS: Structured reports are superior to FTR with regard to formal aspects, completeness, clinical utility, and overall satisfaction of referring pulmonologists.
Subject(s)
Lung Transplantation , Medical Records/standards , Postoperative Complications/diagnostic imaging , Tomography, X-Ray Computed/methods , Adult , Aged , Female , Humans , Lung/diagnostic imaging , Male , Middle Aged , Retrospective Studies , Young AdultSubject(s)
Medical Records , Humans , Medical Records/standards , Patients , Physician-Patient Relations/ethics , RespectABSTRACT
BACKGROUND: We used a structured approach to validate chemotherapy information derived from a national routinely collected chemotherapy dataset and from national administrative hospital data. METHODS: 10,280 patients who had surgical resection with stage III colon cancer were included. First, we compared information derived from the national chemotherapy dataset (SACT) and from the administrative hospital dataset (HES) in the English NHS with respect to receipt of adjuvant chemotherapy (ACT). Second, we compared regimen and number of cycles in linked patient-level records. Third, we carried out a sensitivity analysis to establish to what extent the impact of ACT receipt differed according to data source. RESULTS: 6,012 patients (58 %) received ACT according to either dataset. Of these patients, 3,460 (58 %) had ACT records in both datasets, 1,649 (27 %) in SACT alone, and 903 (15 %) in HES alone. Of the 3,460 patients with records in both datasets, 3,320 (96 %) had matching regimens. There was good agreement on cycle number with similar proportions of patients recorded with a single cycle (6 % in SACT vs. 7 % in HES) and slightly fewer patients recorded with more than 8 cycles in SACT (32 % in SACT vs. 35 % in HES). 3-year cancer-specific mortality was similar for patients receiving ACT, regardless of whether a patient received ACT according to SACT alone (16.6 %), according to HES alone (16.8 %), or according to either SACT or HES (17.1 %). CONCLUSION: Routinely collected national chemotherapy data and administrative hospital data are highly accurate in recording regimen and number of chemotherapy cycles. However, chemotherapy information should ideally be captured from both datasets to avoid under-capture, particularly of oral chemotherapy from administrative hospital data, and to minimise bias.
Subject(s)
Colonic Neoplasms , Medical Records , Chemotherapy, Adjuvant , Cohort Studies , Colonic Neoplasms/drug therapy , Colonic Neoplasms/epidemiology , England , Humans , Medical Records/standards , Reproducibility of Results , State MedicineABSTRACT
BACKGROUND: The rate of suicide in the US has increased substantially in the past two decades, and new insights are needed to support prevention efforts. The National Violent Death Reporting System (NVDRS), the nation's most comprehensive registry of suicide mortality, has qualitative text narratives that describe salient circumstances of these deaths. These texts have great potential for providing novel insights about suicide risk but may be subject to information bias. OBJECTIVE: To examine the relationship between decedent characteristics and the presence and length of NVDRS text narratives (separately for coroner/medical examiner (C/ME) and law enforcement (LE) reports) among 233,108 suicide and undetermined deaths from 2003-2017. METHODS: Generalized estimating equations (GEE) logistic and quasi-Poisson modeling was used to examine variation in the narratives (proportion of missing texts and character length of the non-missing texts, respectively) as a function of decedent age, sex, race/ethnicity, education, marital status, military history, and homeless status. Models adjusted for site, year, location of death, and autopsy status. RESULTS: The frequency of missing narratives was higher for LE vs. C/ME texts (19.8% vs. 5.2%). Decedent characteristics were not consistently associated with missing text across the two types of narratives (i.e., Black decedents were more likely to be missing the LE narrative but less likely to be missing the C/ME narrative relative to non-Hispanic whites). Conditional on having a narrative, C/ME were significantly longer than LE (822.44 vs. 780.68 characters). Decedents who were older, male, had less education and some racial/ethnic minority groups had shorter narratives (both C/ME and LE) than younger, female, more educated, and non-Hispanic white decedents. CONCLUSION: Decedent characteristics are significantly related to the presence and length of narrative texts for suicide and undetermined deaths in the NVDRS. Findings can inform future research using these data to identify novel determinants of suicide mortality.
Subject(s)
Forensic Medicine/standards , Medical Records/standards , Suicide, Completed/statistics & numerical data , Adolescent , Adult , Aged , Aged, 80 and over , Data Interpretation, Statistical , Female , Forensic Medicine/statistics & numerical data , Humans , Male , Medical Records/statistics & numerical data , Middle Aged , Mortality/trends , Socioeconomic Factors , United StatesABSTRACT
Pathologists often incorporate modifying phrases in their diagnosis to imply varying levels of diagnostic certainty; however, what is implied by the pathologists is not equivalent with what is perceived by the referring physicians and patients. This discordance can have significant implications in management, safety, and cost. We intend to identify lack of consistency in interpretation of modifying phrases by comparing perceived level of certainty by pathologists and non-pathologists, and introduce a standard scheme for reporting uncertainty in pathology reports using the experience with imaging reporting and data systems. In this study, a list of 18 most commonly used modifying phrases in pathology reports was distributed among separate cohorts of pathologists (N = 17) and non-pathology clinicians (N = 225) as a questionnaire survey, and the participants were asked to assign a certainty level to each phrase. All the participants had practice privileges in Brown University-affiliated teaching hospitals. The survey was completed by 207 participants (17 pathologists, 190 non-pathologists). It reveals a significant discordance between the interpretations of the modifying phrases between the two cohorts, with significant variations in subgroups of non-pathology clinicians. Also there is disagreement between pathologists and other clinicians regarding the causes of miscommunication triggered by pathology reports. Pathologists and non-pathology clinicians should be mindful of the potential sources of misunderstanding of pathology reports and take necessary actions to prevent and clarify the uncertainties. Using a standard scheme for reporting uncertainty in pathology reports is recommended.